Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Henriques

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Clinical Colorectal Cancer|June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical PredictorsLea Jehanno, Julie Henriques, Thomas Samaille, et al.
JCO Oncology Practice|March 26, 2026
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting StomaAndrea Marques, Julie Henriques, Dewi Vernerey, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 24, 2019
Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional HerniaYohann Renard, Louis de Mestier, Julie Henriques, et al.
Plos One|January 21, 2016
Bedside Evaluation of the Functional Organization of the Auditory Cortex in Patients with Disorders of ConsciousnessJulie Henriques, Lionel Pazart, Lyudmila Grigoryeva, et al.
Annals of Surgery|August 5, 2024
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 TrialJean Pinson, Julie Henriques, Ludivine Beaussire, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2020
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinomaPaul McLellan, Julie Henriques, Feryel Ksontini, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Exposure-response analysis of Raltitrexed assessing liver toxicityBernard Royer, Antonin Schmitt, Thierry Nguyen, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical ActivityPauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
Frontiers in Oncology|March 28, 2022
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective PatientsEmeline Orillard, Julie Henriques, Dewi Vernerey, et al.
Bulletin Du Cancer|December 19, 2022
Matthieu Delaye, Eric Assenat, Emmanuel Boleslawski, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Clinical Colorectal Cancer|June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical PredictorsLea Jehanno, Julie Henriques, Thomas Samaille, et al.
JCO Oncology Practice|March 26, 2026
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting StomaAndrea Marques, Julie Henriques, Dewi Vernerey, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 24, 2019
Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional HerniaYohann Renard, Louis de Mestier, Julie Henriques, et al.
Plos One|January 21, 2016
Bedside Evaluation of the Functional Organization of the Auditory Cortex in Patients with Disorders of ConsciousnessJulie Henriques, Lionel Pazart, Lyudmila Grigoryeva, et al.
Annals of Surgery|August 5, 2024
New Biomarkers to Define a Biological Borderline Situation for Pancreatic Adenocarcinoma: Results of an Ancillary Study of the PANACHE01-PRODIGE48 TrialJean Pinson, Julie Henriques, Ludivine Beaussire, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2020
Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinomaPaul McLellan, Julie Henriques, Feryel Ksontini, et al.
British Journal of Clinical Pharmacology|August 14, 2020
Exposure-response analysis of Raltitrexed assessing liver toxicityBernard Royer, Antonin Schmitt, Thierry Nguyen, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 18, 2025
Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical ActivityPauline Parent, Frédéric Pigneur, Marc Hilmi, et al.
Frontiers in Oncology|March 28, 2022
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective PatientsEmeline Orillard, Julie Henriques, Dewi Vernerey, et al.
Bulletin Du Cancer|December 19, 2022
Matthieu Delaye, Eric Assenat, Emmanuel Boleslawski, et al.
Pageof 6